Biotech · Private company
Enyo Pharma
Track this companyFree. Adds Enyo Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- VonafexorPhase 2 · Alport SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- VonafexorPhase 2 · Non-alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)PHASE2 · COMPLETED · started Aug 1, 2024ClinicalTrials.gov NCT06425055 · fetched Nov 12, 2026
- Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Jan 30, 2019ClinicalTrials.gov NCT03812029 · fetched Nov 12, 2026